Top Industry Leaders in the erythropoietin drug market
Johnson & Johnson Services, Inc. continues to hold a significant market share with its Procritยฎ and Epogenยฎ brands, but faces competition from biosimilars like Amgen's Epoetin Alfa-NX and Teva's Epoetin alfa.
Roche is developing a new erythropoietin drug called Roxifilan for the treatment of anemia in patients with cancer.
Celltrion is expanding its presence in the market with its biosimilar erythropoietin drug Remsimaยฎ, which is approved for the treatment of several conditions, including anemia in cancer patients.
List of erythropoietin drug Key Companies in the Market
โข Hoffmann-La Roche
โข Johnson & Johnson
โข Amgen
โข Kyowa Hakko Kirin
โข Intas Pharmaceuticals
โข Teva Pharmaceutical Industries Ltd.
โข Biocon
โข Emcure Pharmaceuticals
โข Celltrion Inc.
ย
โข Hospira